Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
66%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
HHL.TO
24
HOLDINGS
70%
ALSO IN MEDX.TO
MEDX.TO
22
HOLDINGS
78%
ALSO IN HHL.TO
SECTOR DRIFT (HHL.TO minus MEDX.TO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HHL.TO |
Weight in MEDX.TO |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 5.6% | 5.5% | 5.5% | |
| ASTRAZENECA PLC | 5.0% | 5.2% | 5.0% | |
| MERCK & CO. INC. | 5.0% | 5.2% | 5.0% | |
| ABBVIE INC | 5.1% | 5.0% | 5.0% | |
| JOHNSON & JOHNSON | 4.9% | 5.1% | 4.9% | |
HHL.TO Overweight Relative to MEDX.TO
| UNITEDHEALTH GROUP INC | 5.3% | |
| ELEVANCE HEALTH INC | 5.3% | |
| NOVARTIS AG-ADR | 5.1% | |
| REGENERON PHARMACEUTICALS | 4.9% | |
| AGILENT TECHNOLOGIES INC | 4.8% | |
| BOSTON SCIENTIFIC CORP | 4.5% | |
| ABBOTT LABORATORIES | 0.3% | |
| ABBVIE INC | 0.2% | |
| STRYKER CORP | 0.2% | |
| MEDTRONIC PLC | 0.1% |
HHL.TO Underweight Relative to MEDX.TO
| NOVO-NORDISK A/S-SPONS ADR | -6.3% | |
| PFIZER INC | -5.1% | |
| NOVARTIS AG | -5.1% | |
| GILEAD SCIENCES INC | -4.9% | |
| VERTEX PHARMACEUTICALS INC | -0.7% | |
| BRISTOL-MYERS SQUIBB CO | -0.4% | |
| MERCK & CO. INC. | -0.3% | |
| JOHNSON & JOHNSON | -0.2% | |
| THERMO FISHER SCIENTIFIC INC | -0.2% | |
| ASTRAZENECA PLC | -0.2% |